State Street SPDR S&P Pharmaceuticals vs First Trust NYSE Arca Biotech: Which Is the Better ETF For Your Portfolio?
2026-06-04 13:33:26 ET
The State Street SPDR S&P Pharmaceuticals ETF (NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides concentrated exposure to biotechnology.
Investors seeking healthcare exposure often choose between mature pharmaceutical giants and high-growth biotechnology firms. This comparison examines how these two funds approach their respective sub-sectors, balancing the established cash flows of pharmaceuticals with the research-driven potential and the higher concentration of biotech innovators that populate the healthcare landscape.
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
NASDAQ: XPH
XPH Trading
3.44% G/L:
$58.07 Last:
49,270 Volume:
$56.70 Open:
